6th Exosome-Based Therapeutic Development Summit
Evvnt Promotion / evvnt
Archiv
17.09.2024 - 19.09.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
Kongressthemen
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Anfragen und Anmeldung:
https://go.evvnt.com/2433871-2?pid=4832
Frau Erin Thomas
Gesundheitsversorgung, Public Health
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
